L. Edwards
Royal Hospital for Women(AU)Westmead Hospital(AU)Sydney Local Health District(AU)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, DNA Repair Mechanisms, Endometrial and Cervical Cancer Treatments, BRCA gene mutations in cancer
Most-Cited Works
- → Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma(2018)282 cited
- → Overexpression of the Cell Adhesion Molecules DDR1, Claudin 3, and Ep-CAM in Metaplastic Ovarian Epithelium and Ovarian Cancer(2004)209 cited
- → Prognostic gene expression signature for high-grade serous ovarian cancer(2020)170 cited
- → Cyclin D1, p53, and p21Waf1/Cip1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian Cancer(2004)147 cited
- → Adjuvant small field pelvic radiation for patients with high risk, Stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection(1999)49 cited
- → Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer(2014)35 cited
- → BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance(2024)24 cited
- → Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer(2024)14 cited
- → Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas(2005)13 cited
- → Malignant perivascular epithelioid cell tumor (PEComa) arising in the broad ligament(2004)12 cited